News

A recent study found that children with a family history of type 2 diabetes show slower progression of type 1 diabetes.

As people with T1D live longer, age-related conditions such as dementia are becoming increasingly important.

Why normal glucose regulation should be the therapeutic goal rather than weight loss

The impact of diabetes on cardiovascular health remains one of the most urgent clinical challenges, influencing outcomes for millions worldwide.

Beta cell protection in new-onset type 1 diabetes, sleep and glycaemic control, EASD Global Impact Prize

SURPASS-CVOT primary results, technology in pregnancy, how to run a lab

New clinical guideline on diabetes distress, challenges to precision medicine in type 2 diabetes, ketone monitoring & minimum safety for CGM

Precision medicine approaches for monogenic diabetes, CGM in India and in exercise, and the emerging consensus on T1D screening

How large is the benefit of combining the GLP-1 and amylin mechanisms of action, and what are the implications for clinical practice?

Phase II trial shows that higher doses of up to 16 mg of the GLP-1 receptor agonist (RA) semaglutide improve glycaemia and induce weight loss at the cost of reduced tolerability.

Early-onset and difficult-to-manage type 2 diabetes, and a new approach to preserve muscle when losing weight

A post-hoc MRI substudy of the SURPASS-3 trial suggests that tirzepatide may improve muscle fat content in people with type 2 diabetes undergoing substantial weight loss.

Cardiovascular benefits of oral GLP-1RA, stagnation in HbA1c target achievement, and a paradigm shift in basal insulin therapy

Assessment of hypos revisited, microbes in type 1 diabetes pathogenesis, and a new class of GLP-1 RA

Hot debates on innovations, high-stakes treatment choices, and CGM as OTC 

The management of persons living with MASLD requires interdisciplinary collaboration to minimise long-term risks and improve patient outcomes.

Obesity is becoming increasingly common among people with type 1 diabetes (T1D), and vice versa.

Viruses are increasingly being explored as contributors to chronic diseases, including in diabetes research.

Inspiring the next generation in diabetes care

A new era for diabetes technology training

A recent study provides evidence that losing more than 10 % of body weight early after diabetes diagnosis can significantly improve longterm glycaemic control and increase remission rates. Based on up to 25 ...